Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
VCYT vs NEO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
VCYT Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)
VCYT Overall Winner
6-Pillar Tally: VCYT 4 – 2 NEO
Matrix Metrics: VCYT 7 – 3 NEO
As of Nov 16, 2026, Veracyte, Inc. (VCYT) is the stronger overall head-to-head candidate over NeoGenomics, Inc. (NEO) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). VCYT carries a Unified Composite Score of 49.1/100 (HOLD) at $24.01 (15.3x Forward P/E, 15.0% operating margin), whereas NEO carries 35.0/100 (SELL) at $15.41 (N/M Forward P/E, -5.5% operating margin).
- Technical & Structure Timing Caution: VCYT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 27.8); meanwhile NEO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About VCYT vs NEO
VCYT
Head-to-Head Winner
Veracyte, Inc.
$24.01
-1.32% 1D
Market Cap
$2.0B
TTM Revenue
$582M
Forward P/E
15.3x
Beta / 30D Vol
3.01β · 199% Vol
Unified Composite Score
49.1
HOLD
Tech 55.0
Fund 56.0
Flow 57.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
NEO
NeoGenomics, Inc.
$15.41
-3.81% 1D
Market Cap
$2.1B
TTM Revenue
$788M
Forward P/E
N/M
Beta / 30D Vol
1.22β · 47% Vol
Unified Composite Score
35.0
SELL
Tech 21.0
Fund 44.0
Flow 58.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (VCYT 4 – 2 NEO)
1. Valuation Multiples
VCYT
Forward P/E
15.3x
N/M
Trailing P/E
15.8x
N/M
PEG Ratio
N/M
2.09x
EV / Revenue
3.1x
3.0x
2. Growth & Scale
NEO
Revenue Growth (YoY)
+15.1%
+11.4%
Earnings Growth (YoY)
+58.3%
+130.6%
TTM Revenue (USD)
$582M
$788M
Market Cap
$2.0B
$2.1B
3. Profitability & Quality
VCYT
Gross Margin
74.2%
44.8%
Operating Margin
15.0%
-5.5%
Net Profit Margin
21.8%
-4.1%
Return on Equity (ROE)
9.4%
-3.9%
4. Balance Sheet & Cash Flow
VCYT
Cash Generation (TTM)
$162M
-$29M
Cash Flow Margin
27.8%
-3.6%
Net Cash / Leverage
$159M Net Cash
$310M Net Debt (0.56x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
NEO
Options Structure Phase
BREAKDOWN
CONSOLIDATION
Current IV / %ile
197.3% (47th %ile)
100.0% (14th %ile)
Put/Call OI Skew
0.01x (Call-Skewed)
0.12x (Call-Skewed)
OBV Trend / Tech Phase
DISTRIBUTION · Markdown
DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat
VCYT
OpEx & R&D Intensity
59.2% of Rev ($344M)
50.3% of Rev ($396M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Scale & Operating Efficiency Moat
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Diagnostics & Research Operator
Diagnostics & Research Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: VCYT (7) vs NEO (3)| Institutional Metric | VCYT | NEO | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $2.0B | $2.1B | NEO | |
| Trailing P/E Ratio | 15.8x | N/M | VCYT | |
| Forward P/E Ratio | 15.3x | N/M | VCYT | |
| Revenue Growth (YoY) | +15.1% | +11.4% | VCYT | |
| Operating Margin (TTM) | 15.0% | -5.5% | VCYT | |
| Net Profit Margin | 21.8% | -4.1% | VCYT | |
| Return on Equity (ROE) | 9.4% | -3.9% | VCYT | |
| 52-Week Range Position | 5% ($22–$61) | 64% ($7–$20) | NEO | |
| Beta / 30D Volatility | 3.01β · 199% Vol | 1.22β · 47% Vol | NEO | |
| Unified Institutional Score | 49.1 / 100 (HOLD) | 35.0 / 100 (SELL) | VCYT | |
| Trailing 12M Revenue (USD) | $582M | $788M | Scale | |
| Gross Profit Margin (TTM) | 74.2% | 44.8% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 3.1x EV/Rev | 2.09x PEG · 3.0x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $162M ($159M Net Cash) | -$29M ($310M Net Debt (0.56x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
NEO +36.87 pp
3M Horizon
NEO +37.9 pp
6M Horizon
NEO +126.25 pp
1Y Horizon
NEO +93.73 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VCYT Revenue | NEO Revenue | VCYT Op. Margin | NEO Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $90M | $280M | -24.2% | 3.6% | NEO |
| FY2019 | $120M | $410M | -12.6% | 3.2% | NEO |
| FY2020 | $120M | $440M | -30.1% | -3.1% | NEO |
| FY2021 | $220M | $480M | -37.3% | -24.5% | NEO |
| FY2022 | $300M | $510M | -13.9% | -30.9% | VCYT |
| FY2023 | $360M | $590M | -23.8% | -18.2% | NEO |
| FY2024 | $450M | $660M | 3.6% | -13.9% | VCYT |
| FY2025 | $520M | $730M | 11.2% | -15.9% | VCYT |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
VCYT
BREAKDOWN
Current IV
197.3%
IV Percentile
47th %ile
Put/Call OI Skew
0.01x (Call-Skewed)
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
DISTRIBUTION
Exact VCYT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
NEO
CONSOLIDATION
Current IV
100.0%
IV Percentile
14th %ile
Put/Call OI Skew
0.12x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact NEO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
VCYT Moat Profile
Scale & Operating Efficiency Moat
Diagnostics & Research Operator
OpEx & R&D Reinvestment
59.2% of Rev ($344M)
90D Engineering Disclosures
0 Published
NEO Moat Profile
Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
OpEx & R&D Reinvestment
50.3% of Rev ($396M)
90D Engineering Disclosures
0 Published
Investor FAQ VCYT vs NEO Key Questions & Quantitative Answers
As of Nov 16, 2026, Veracyte, Inc. (VCYT) is the stronger overall head-to-head candidate over NeoGenomics, Inc. (NEO) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). VCYT carries a Unified Composite Score of 49.1/100 (HOLD) at $24.01 (15.3x Forward P/E, 15.0% operating margin), whereas NEO carries 35.0/100 (SELL) at $15.41 (N/M Forward P/E, -5.5% operating margin). Technical & Structure Timing Caution: VCYT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 27.8); meanwhile NEO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NEO leads the Growth & Scale pillar: VCYT posts +15.1% YoY revenue growth and +58.3% YoY earnings growth on $582M TTM revenue (74.2% gross margin, 15.0% operating margin), compared with NEO at +11.4% YoY revenue growth and +130.6% YoY earnings growth on $788M TTM revenue (44.8% gross margin, -5.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), VCYT cumulative revenue shifted +477.8% while NEO shifted +160.7%. In operating R&D and SG&A reinvestment, VCYT deploys 59.2% of Rev ($344M) (0 90-day corporate R&D disclosures) versus 50.3% of Rev ($396M) (0 disclosures) for NEO.
VCYT screens cheaper on headline valuation multiples. VCYT trades at 15.3x Forward P/E, 15.8x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (27.8% FCF margin), whereas NEO trades at N/M Forward P/E, N/M Trailing P/E, 2.09x PEG, and 3.0x EV/Revenue (-3.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VCYT (9.4% ROE) versus NEO (-3.9% ROE) capital efficiency.
In options market volatility and institutional positioning, VCYT carries 197.3% implied volatility (47th %ile, Balanced (25th–60th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.01β · 199% Vol realized risk). By comparison, NEO carries 100.0% implied volatility (14th %ile, Compressed (<25th %ile)), a 0.12x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.22β · 47% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
NEO vs VCYT · Reverse Pair
VCYT vs CDNA
· Sector Peer
VCYT vs TWST
· Sector Peer
VCYT vs TXG
· Sector Peer
NEO vs NVCR
· Sector Peer
NEO vs GKOS
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem